Deception in the Single-Blind Run-In Phase of Clinical Trials

IRB: Ethics & Human Research 29 (2) (2007)
  Copy   BIBTEX

Abstract

A single-blind run-in phase is often employed in randomized controlled trials. During these types of trials, all participants are given a placebo but are not informed of this fact. In many trials, participants who are judged to be “placebo responders” or who don’t follow instructions for taking the drug are excluded from further participation at the conclusion of this phase. Because participants are not informed of these procedures, this represents the use of deception in research

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,322

External links

  • This entry has no external links. Add one.
Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Justified deception? The single blind placebo in drug research.M. Evans - 2000 - Journal of Medical Ethics 26 (3):188-193.
What makes placebo-controlled trials unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Acupuncture trials and informed consent.F. G. Miller & T. J. Kaptchuk - 2007 - Journal of Medical Ethics 33 (1):43-44.

Analytics

Added to PP
2015-02-05

Downloads
0

6 months
0

Historical graph of downloads

Sorry, there are not enough data points to plot this chart.
How can I increase my downloads?

Citations of this work

Subversive Subjects: Rule-Breaking and Deception in Clinical Trials.Rebecca Dresser - 2013 - Journal of Law, Medicine and Ethics 41 (4):829-840.
Subversive Subjects: Rule‐Breaking and Deception in Clinical Trials.Rebecca Dresser - 2013 - Journal of Law, Medicine and Ethics 41 (4):829-840.

Add more citations

References found in this work

No references found.

Add more references